Management of Elevated INR

Introduction to Elevated INR Management

The American Geriatrics Society recommends that for INR between 5.0 and 9.0, the next 1-2 doses of warfarina should be suspended, and if the patient has a high risk of bleeding, oral vitamin K1 (1.0-2.5 mg) should be administered 2, 1
The European Heart Journal suggests that for INR greater than 9.0, warfarina should be completely suspended, and oral vitamin K1 (2.5-5 mg) should be administered, with INR monitoring within the first 24 hours 3, 4

For INR between 4.0 and 5.0, the next dose of warfarina should be suspended, and INR should be monitored in 24-48 hours, as recommended by the American College of Cardiology 1
For INR between 5.0 and 9.0, warfarina should be suspended for 1-2 doses, and oral vitamin K1 (1.0-2.5 mg) should be administered if the patient has a high risk of bleeding, according to the Journal of the American Geriatrics Society 2, 1
For INR greater than 9.0, warfarina should be completely suspended, and oral vitamin K1 (2.5-5 mg) should be administered, with consideration of using fresh frozen plasma if INR is >10.0, as suggested by the European Heart Journal 3, 4

For minor bleeding, warfarina should be suspended, and oral vitamin K1 (2.0-4.0 mg) should be administered, with additional doses of vitamin K1 (1.0-2.0 mg) if INR remains elevated after 24 hours, as recommended by the Journal of the American Geriatrics Society 2
For major or potentially life-threatening bleeding, hospitalization is required, and vitamin K1 (5-10 mg) should be administered by slow intravenous infusion, along with prothrombin complex concentrate, according to the International Journal of Stroke 5, 1

In patients with prosthetic heart valves and elevated INR without bleeding, vitamin K should not be used intravenously due to the risk of valvular thrombosis, and hospitalization is recommended to allow INR to decrease gradually, as suggested by the European Heart Journal 4
In patients with intracranial hemorrhage, anticoagulation should always be reversed, and anticoagulation can be resumed after 1 week, as recommended by the European Heart Journal 4

INR should be monitored within 24-48 hours after any intervention, and the cause of elevated INR should be investigated, including medication interactions, dietary changes, and diseases, according to the American College of Cardiology 1, 3
The frequency of INR monitoring should be increased until stability is achieved, and INR normally returns to normal in 4-5 days after warfarina is suspended, as suggested by the American College of Cardiology 1, 6

Administering high doses of vitamin K1 (e.g., 10 mg) unnecessarily, which can cause resistance to warfarina for up to a week, as warned by the American College of Cardiology 1
Administering vitamin K intravenously when not necessary, due to the risk of anaphylactic reactions, according to the American College of Cardiology 3
Not investigating the underlying cause of elevated INR, which can lead to recurrences, as emphasized by the American College of Cardiology 3